Back to search

Article

Identification of BCL11A, NTN5, and OGN as diagnosis biomarker of papillary renal cell carcinomas by bioinformatic analysis

2024-03-08

Abstract excerpt

The prevalence of papillary renal cell carcinomas is estimated to be between 10% and 15. At this time, there is no effective therapeutic approach available for patients with advanced PRCCs. The molecular biomarkers associated with PRCC diagnoses have been rarely studied compared to renal clear cell carcinomas, therefore it is imperative that novel molecular biomarkers be identified to aid in the early identificati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
537af20f-8a86-50c1-94b2-145a17386c00
DOI
10.21203/rs.3.rs-3960958/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of BCL11A, NTN5, and OGN as diagnosis biomarker of papillary renal cell carcinomas by bioinformatic analysisDOI 10.21203/rs.3.rs-3960958/v1
Select a neighboring publication to make it the new centre.